Affordable Inhalers and Nebulizers Act of 2025

This bill would require private health plans and insurers to cover all inhaler drugs and related equipment, such as nebulizers, spacers, and masks, used to treat asthma and chronic obstructive pulmonary disease (COPD). Plans could not apply a deductible to these products and could not charge patients more than $15 per 30-day supply, starting with plan years beginning January 1, 2026. The same $15 limit and no-deductible rule would apply under Medicare Part B and Part D. The bill would also create a federal program, subject to available funding, to pay registered providers who supply these products to uninsured people, if the providers agree to charge those patients no more than $15 for a month's supply.

Full text and official record on Congress.gov

Sponsors

• Angela D. Alsobrooks Democrat sponsor
• 2 cosponsors